Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
232.34
+18.90 (8.85%)
At close: Apr 14, 2026, 4:00 PM EDT
231.39
-0.95 (-0.41%)
After-hours: Apr 14, 2026, 4:19 PM EDT
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$5,703,979
Profits / Employee
$2,647,936
Market Cap
4.63B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Apellis Pharmaceuticals | 739 |
| Corcept Therapeutics | 730 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| TG Therapeutics | 399 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 362 |
| Spyre Therapeutics | 102 |
LGND News
- 15 hours ago - Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS - GlobeNewsWire
- 19 days ago - Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team - GlobeNewsWire
- 4 weeks ago - Ligand Pharmaceuticals Is A Low-Risk Way To Bet On Biopharma Growth: Analyst - Benzinga
- 5 weeks ago - Ligand to Participate in March Investor Conferences - GlobeNewsWire
- 6 weeks ago - Ligand Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 2 months ago - Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - GlobeNewsWire